GUIDELINE REVIEW
SIGN guideline on bronchiolitis in infants
Correspondence to:
For correspondence:
Dr J H Baumer
Consultant Paediatrician, Derriford Hospital, Plymouth, Devon PL6 8DH, UK; harry.baumer@phnt.swest.nhs.uk
| The first 150 words of the full text of this article appear below. |
A predictable event in the paediatricians year is the advent of the bronchiolitis season somewhere around November or December, with large numbers of hospital admissions of infants, especially those under 6 months of age. This continues to occur despite recent developments including the availability of palivizumab for prophylaxis in high-risk infants.
The Scottish Intercollegiate Guidelines Network (SIGN) published an evidence-based guideline on the condition in November 2006.1 The guidelines purpose is to reduce some of the reported variations in management, avoiding unnecessary tests and interventions. It covers prevention; recognition and differential diagnosis; indications for hospital admission and the in-patient management of infants with bronchiolitis; limiting disease transmission, and prognosis. Its scope includes infants up to 12 months of age and excludes management in intensive care.
This review highlights those aspects particularly relevant to paediatricians. The other recommendations in the guideline can readily be accessed from the SIGN website (http://www.sign.ac.uk
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.



